Printer-friendly version

Alzheimer Dementia, sporadic, association marker APOE

Neurology 10.006

Alzheimer Dementia, sporadic, association marker APOE

AD2

Signs/symptoms: Dementia, late onset, sporadic
Complications: Neuritic plaques and neurons with neurofibrillary tangles.
Early diagnosis/treatment: Yes
Association between the apolipoprotein E4 variant (C112R) and sporadic Alzheimer's disease (AD).

Material required:

Blood tubes: EDTA whole blood (do not freeze, do not centrifugate)
Mouth brush: Yes
Chromosomal localization: 19q13.2 OMIM number: 107741

Apolipoprotein E (main plus additional mutations)

APOE

Gene regions tested:

Gene regions: E4-Variants
Amino acid positions: C112R, R158C, R136S, A106V
Nucleotide positions:
Test methods: Restriction Fragment Length

Prices:

Switzerland:

8820.00 8811.01 8818.00 8055.00
  TP REVAL: 200 TP Value: 0.9 CHF 180.00
Other europe: EUR 130.00
Other regions: USD call

References:

Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KE, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180-184.
Corder, E. H.; Saunders, A. M.; Strittmatter, W. J.; Schmechel, D. E.; Gaskell, P. C.; Small, G. W.; Roses, A. D.; Haines, J. L.; Pericak-Vance, M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923, 1993.

Browse Gene Tests

To view all our gene tests, please visit our Test Menu.